(±)-NBI 74330
Tocris Bioscience, part of Bio-Techne | Catalog # 4528
Potent and selective CXCR3 antagonist
Key Product Details
Description
Potent and selective CXCR3 antagonist
Product Description
(±)-NBI 74330 is a potent and selective CXCR3 antagonist; potently inhibits 125I-CXCL10 binding to CXCR3 (pKi = 8.13). Inhibits calcium mobilization in response to CXCL11 and CXCL10 in RBL cells. Exhibits no significant effect on chemotaxis induced by CXCR4 or CCR7. Displays a five-fold greater affinity for CXCR3 than (±)-AMG 487.This product is racemic.
Product Specifications
Molecular Weight
605.58
Formula
C32H27F4N5O3
Storage
Store at -20°C
Purity
≥98% (HPLC)
Chemical Name
N-1-[(3-4(-Ethoxyphenyl)-3,4-dihydro-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-4-fluoro-N-(3-pyridinylmethyl)-3-(trifluoromethyl)benzeneacetamide
CAS Number
473722-68-8
PubChem ID
10167713
InChI Key
XMRGQUDUVGRCBS-UHFFFAOYSA-N
SMILES
CCOC(C=C3)=CC=C3N2C(C1=CC=CN=C1N=C2C(N(CC4=CC=CN=C4)C(CC5=CC(C(F)(F)F)=C(F)C=C5)=O)C)=O
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 30.28 | 50 |
Preparing Stock Solutions
for (±)-NBI 74330
The following data is based on the product molecular weight 605.58
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.5 mM | 3.30 mL | 16.51 mL | 33.03 mL |
| 2.5 mM | 0.66 mL | 3.30 mL | 6.61 mL |
| 5 mM | 0.33 mL | 1.65 mL | 3.30 mL |
| 25 mM | 0.07 mL | 0.33 mL | 0.66 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Verzijl Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors. J.Pharmacol.Exp.Ther. 2008 PMID: 18270317
- Heise Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist. J.Pharmacol.Exp.Ther. 2005 PMID: 15761110
- Storelli Synthesis and structure-activity relationships of 3H-quinazolin-4-ones and 3H-pyrido[2,3-d]pyrimidin-4-ones as CXCR3 receptor antagonists. Arch.Pharm. 2007 PMID: 17562560
Product Specific Notices for (±)-NBI 74330
For research use only
Loading...
Loading...